Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Melanie Heiss"'
Autor:
Cornelis M. van Tilburg, Ruth Witt, Melanie Heiss, Kristian W. Pajtler, Christoph Plass, Isabel Poschke, Michael Platten, Inga Harting, Oliver Sedlaczek, Angelika Freitag, David Meyrath, Lenka Taylor, Gnana Prakash Balasubramanian, Natalie Jäger, Elke Pfaff, Barbara C. Jones, Till Milde, Stefan M. Pfister, David T. W. Jones, Annette Kopp-Schneider, Olaf Witt
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Pediatric patients with relapsed or refractory disease represent a population with a desperate medical need. The aim of the INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) program is to translate next genera
Externí odkaz:
https://doaj.org/article/ef3446831b4b419a8809bb6d0c15b3ea
Autor:
Cornelis Martinus van Tilburg, Melanie Heiss, Ingrid Øra, Andreas Beilken, Uta Dirksen, Nicholas G. Gottardo, Dong-Anh Khuong-Quang, Jordan Hansford, Caroline Hutter, Jasper Van der Lugt, Anne Thorwarth, Isabel Poschke, Inga Harting, Oliver Sedlaczek, Pengbo Beck, Angelika Freitag, David T.W. Jones, Natalie Jäger, Annette Kopp-Schneider, Olaf Witt
10034 Background: Pediatric patients with relapsed or refractory high-risk solid and CNS tumors have dismal survival. To date treatment with immune checkpoint inhibitors in this population has been disappointing. This study exploits the immune enhanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fee1380240849271857bbb6d8e0f243
Autor:
Barbara C. Jones, David T.W. Jones, Oliver Sedlaczek, Isabel Poschke, Till Milde, Melanie Heiss, Olaf Witt, Kristian W. Pajtler, Lenka A. Taylor, Annette Kopp-Schneider, Michael Platten, Inga Harting, Christoph Plass, Stefan M. Pfister, Natalie Jäger, David Meyrath, Gnana Prakash Balasubramanian, Ruth Witt, Cornelis M. van Tilburg, Elke Pfaff, Angelika Freitag
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Background Pediatric patients with relapsed or refractory disease represent a population with a desperate medical need. The aim of the INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) program is to translate next generation mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a221c569d3b984612ec35962d2e3b66f
https://pubmed.ncbi.nlm.nih.gov/32503469
https://pubmed.ncbi.nlm.nih.gov/32503469